 Bank of New York Mellon Corp trimmed its position in Kalvista Pharmaceuticals Inc NASDAQ:KALV by 5.1 in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 34,999 shares of the specialty pharmaceutical companys stock after selling 1,900 shares during the quarter. Bank of New ... 